Integra LifeSciences Holdings Corporation Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 3 | $0.55 | $0.55 | $0.55 |
Q2 2024 | 6 | $0.62 | $0.62 | $0.62 |
Q3 2024 | 8 | $0.39 | $0.39 | $0.39 |
Q4 2024 | 10 | $0.85 | $0.88 | $0.86 |
Q1 2025 | 6 | $0.53 | $0.60 | $0.57 |
Q2 2025 | 5 | $0.58 | $0.61 | $0.59 |
Q3 2025 | 5 | $0.54 | $0.57 | $0.55 |
Q4 2025 | 5 | $0.79 | $0.83 | $0.80 |
Q1 2026 | 2 | $0.60 | $0.63 | $0.62 |
Q2 2026 | 2 | $0.65 | $0.68 | $0.67 |
Q3 2026 | 2 | $0.66 | $0.70 | $0.68 |
Q4 2026 | 2 | $0.85 | $0.89 | $0.87 |
Integra LifeSciences Holdings Corporation Earnings Date And Information
Integra LifeSciences Holdings Corporation last posted its earnings results on Monday, November 4th, 2024. The company reported $0.41 earnings per share for the quarter, topping analysts' consensus estimates of $0.39 by $0.02. The company had revenue of 380.83 M for the quarter and had revenue of 1.54 B for the year. Integra LifeSciences Holdings Corporation has generated $1 earnings per share over the last year ($0.84 diluted earnings per share) and currently has a price-to-earnings ratio of -296.73. Integra LifeSciences Holdings Corporation has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 19th, 2025 based on prior year's report dates.
Integra LifeSciences Holdings Corporation Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/04/2024 | Q3 2024 | $0.39 | -$0.14 | -0.53 | $375.81 M | $380.83 M |
07/29/2024 | Q2 2024 | $0.62 | -$0.16 | -0.78 | $413.07 M | $418.18 M |
05/06/2024 | Q1 2024 | $0.55 | -$0.04 | -0.59 | $368.87 M | |
12/30/2023 | Q4 2023 | $0.25 | $397.04 M | |||
10/25/2023 | Q3 2023 | $0.78 | $0.24 | -0.54 | $387.22 M | $382.42 M |
07/27/2023 | Q2 2023 | $0.05 | $374.01 M | $381.27 M | ||
04/26/2023 | Q1 2023 | $0.74 | $0.30 | -0.44 | $380.85 M | |
02/22/2023 | Q4 2022 | $0.93 | $0.63 | -0.3 | $398.02 M | |
10/26/2022 | Q3 2022 | $0.72 | $0.60 | -0.12 | $378.33 M | $385.19 M |
07/27/2022 | Q2 2022 | $0.80 | $0.54 | -0.26 | $395.35 M | $397.82 M |
04/27/2022 | Q1 2022 | $0.68 | $0.39 | -0.29 | $376.64 M | |
02/24/2022 | Q4 2021 | $0.54 | $405.52 M | |||
11/02/2021 | Q3 2021 | $0.72 | $0.51 | -0.21 | $384.62 M | $386.86 M |
07/29/2021 | Q2 2021 | $0.41 | $376.11 M | $389.99 M | ||
04/29/2021 | Q1 2021 | $0.54 | $360.07 M | |||
02/23/2021 | Q4 2020 | $1.10 | $388.65 M | |||
10/29/2020 | Q3 2020 | $0.38 | $351.65 M | $370.23 M | ||
08/10/2020 | Q2 2020 | $0.08 | -$0.00 | -0.08 | $243.82 M | $258.67 M |
05/07/2020 | Q1 2020 | $0.60 | $0.11 | -0.49 | $354.32 M | |
02/20/2020 | Q4 2019 | $0.18 | $395.13 M |
Integra LifeSciences Holdings Corporation Earnings: Frequently Asked Questions
-
When is Integra LifeSciences Holdings Corporation's earnings date?
Integra LifeSciences Holdings Corporation has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 19th, 2025 based off last year's report dates.
-
Did Integra LifeSciences Holdings Corporation beat their earnings estimates last quarter?
In the previous quarter, Integra LifeSciences Holdings Corporation (:IART) reported $0.41 earnings per share (EPS) to beat the analysts' consensus estimate of $0.39 by $0.02.
-
How can I listen to Integra LifeSciences Holdings Corporation's earnings conference call?
The conference call for Integra LifeSciences Holdings Corporation's latest earnings report can be listened to online.
-
How can I read Integra LifeSciences Holdings Corporation's conference call transcript?
The conference call transcript for Integra LifeSciences Holdings Corporation's latest earnings report can be read online.
-
How much revenue does Integra LifeSciences Holdings Corporation generate each year?
Integra LifeSciences Holdings Corporation (:IART) has a recorded annual revenue of $1.54 B.
-
How much profit does Integra LifeSciences Holdings Corporation generate each year?
Integra LifeSciences Holdings Corporation (:IART) has a recorded net income of $1.54 B. Integra LifeSciences Holdings Corporation has generated $0.85 earnings per share over the last four quarters.
-
What is Integra LifeSciences Holdings Corporation's price-to-earnings ratio?
Integra LifeSciences Holdings Corporation (:IART) has a price-to-earnings ratio of -296.73 and price/earnings-to-growth ratio is 2.25.